| scholarly article | Q13442814 |
| P2093 | author name string | Xin Zhou | |
| Ji-Hong Zhao | |||
| Yu-Ming Li | |||
| Ying-Ying Zhang | |||
| Tao Luo | |||
| Rui Shi | |||
| Wen-Jie Ji | |||
| Jin-Long Li | |||
| Tie-Min Jiang | |||
| Jian-Qi Zhang | |||
| Guo-Hong Yang | |||
| Rui-Yi Lu | |||
| P2860 | cites work | Microparticles: major transport vehicles for distinct microRNAs in circulation | Q35792749 |
| Macrophage microvesicles induce macrophage differentiation and miR-223 transfer | Q36595322 | ||
| ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association | Q37768299 | ||
| Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations | Q37867787 | ||
| Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases | Q38040050 | ||
| microRNA-223 promotes the growth and invasion of glioblastoma cells by targeting tumor suppressor PAX6. | Q39106354 | ||
| NLRP3 inflammasome activity is negatively controlled by miR-223. | Q39277506 | ||
| Prospective study on circulating MicroRNAs and risk of myocardial infarction | Q39583273 | ||
| Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans | Q41412919 | ||
| Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment? | Q43279859 | ||
| Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles | Q44791838 | ||
| Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases | Q45213002 | ||
| Calcium-channel blockers reduce the antiplatelet effect of clopidogrel | Q46248005 | ||
| Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel | Q46321321 | ||
| Platelet microRNAs: Novy Mir* or mired in human complexity? | Q46520262 | ||
| Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study | Q46802481 | ||
| The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis. | Q50847978 | ||
| Association of cytochrome P450 2C19*2 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents. | Q53418798 | ||
| Circulating microRNAs as novel biomarkers for platelet activation. | Q54277423 | ||
| 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiol | Q55056448 | ||
| High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study | Q60018122 | ||
| Effect of CYP2C19*2 and *3 loss-of-function alleles on platelet reactivity and adverse clinical events in East Asian acute myocardial infarction survivors treated with clopidogrel and aspirin | Q82300414 | ||
| A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation | Q84117546 | ||
| High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes | Q84582096 | ||
| Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity | Q86404523 | ||
| ??? | Q22242895 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? | Q26992023 | ||
| Intercellular transport of microRNAs | Q27004360 | ||
| High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome | Q28194081 | ||
| Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation | Q28196513 | ||
| A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis | Q29619201 | ||
| MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism | Q29871002 | ||
| Smoking, clopidogrel, and mortality in patients with established cardiovascular disease | Q33621896 | ||
| Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy | Q34019082 | ||
| Existence of a microRNA pathway in anucleate platelets | Q34025954 | ||
| MiR-223 suppresses cell proliferation by targeting IGF-1R. | Q34071730 | ||
| MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation | Q34079793 | ||
| Thrombosis as an intravascular effector of innate immunity | Q34316343 | ||
| Cytochrome p-450 polymorphisms and response to clopidogrel | Q34910228 | ||
| MicroRNA function in myeloid biology | Q35220370 | ||
| P433 | issue | 1 | |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 65-72 | |
| P577 | publication date | 2014-07-01 | |
| P1433 | published in | Journal of Thrombosis and Thrombolysis | Q15766541 |
| P1476 | title | Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome. | |
| P478 | volume | 38 |
| Q59152443 | Circulating ectosomes: Determination of angiogenic microRNAs in type 2 diabetes |
| Q47980408 | Clopidogrel in Critically Ill Patients |
| Q36003227 | Coronary Artery-Bypass-Graft Surgery Increases the Plasma Concentration of Exosomes Carrying a Cargo of Cardiac MicroRNAs: An Example of Exosome Trafficking Out of the Human Heart with Potential for Cardiac Biomarker Discovery |
| Q48026575 | Discordance Between VASP Phosphorylation and Platelet Aggregation in Defining High On-Clopidogrel Platelet Reactivity After ST-Segment Elevation Myocardial Infarction. |
| Q47571604 | Gender and cardiovascular disease: are sex-biased microRNA networks a driving force behind heart failure with preserved ejection fraction in women? |
| Q38531858 | Gene Expression Signatures and the Spectrum of Coronary Artery Disease |
| Q33686324 | Hematopoietic Deficiency of miR-223 Attenuates Thrombosis in Response to Photochemical Injury in Mice |
| Q64948132 | Impact of genetic polymorphisms on platelet function and response to anti platelet drugs. |
| Q36912465 | Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis. |
| Q36845623 | MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells |
| Q37680890 | MicroRNAs and Cardiovascular Disease in Diabetes Mellitus |
| Q38543354 | MicroRNAs in platelet function and cardiovascular disease |
| Q26795583 | Microparticles That Form Immune Complexes as Modulatory Structures in Autoimmune Responses |
| Q91707632 | Monitoring of platelet function parameters and microRNA expression levels in patients with prostate cancer treated with volumetric modulated arc radiotherapy |
| Q37724614 | Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives |
| Q94476029 | Platelet microRNA-15b protects against high platelet reactivity in patients undergoing percutaneous coronary intervention through Bcl-2-mediated platelet apoptosis |
| Q58096370 | Platelet microRNAs in hypertensive patients with and without cardiovascular disease |
| Q26801874 | The Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet Therapy |
| Q52608599 | The Potential Role of Platelet-Related microRNAs in the Development of Cardiovascular Events in High-Risk Populations, Including Diabetic Patients: A Review. |
| Q47701069 | Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links. |
Search more.